PRESS RELEASE published on 11/24/2025 at 17:58, 9 months 27 days ago Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer Heidelberg Pharma appoints Dr. Dongzhou Jeffery Liu as Chairman and CEO, replacing Prof. Andreas Pahl. The biotech company focuses on ADC technology for cancer treatment Cancer Treatment Heidelberg Pharma ADC Technology Executive Management Board Dongzhou Jeffery Liu
BRIEF published on 11/24/2025 at 15:09, 9 months 27 days ago Heidelberg Pharma Appoints New CEO Amidst Executive Changes Executive Changes Biotech Industry Heidelberg Pharma ADCs Dr. Dongzhou Liu
BRIEF published on 11/24/2025 at 15:09, 9 months 27 days ago Heidelberg Pharma nomme un nouveau PDG dans un contexte de changements au sein de sa direction Heidelberg Pharma Industrie Biotechnologique Changements Exécutifs Dr Dongzhou Liu CAN
PRESS RELEASE published on 11/24/2025 at 15:04, 9 months 27 days ago EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer Chairman CEO Heidelberg Pharma AG Executive Management Board Dr. Dongzhou Jeffery Liu
BRIEF published on 11/06/2025 at 07:14, 10 months 16 days ago Essai clinique sur le HDP-101 d'Heidelberg Pharma dans le myélome multiple Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple Technologie ATAC
BRIEF published on 11/06/2025 at 07:14, 10 months 16 days ago Heidelberg Pharma's HDP-101 Advances in Multiple Myeloma Trial Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Technology
PRESS RELEASE published on 11/06/2025 at 07:09, 10 months 16 days ago Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma Heidelberg Pharma's lead ATAC candidate HDP-101 shows promising progress in Phase I/IIa trial for multiple myeloma, including stringent complete remissions. R&D webinar scheduled on 11 Nov 2025 Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Candidate Phase I/IIa Trial
BRIEF published on 11/03/2025 at 10:12, 10 months 19 days ago Heidelberg Pharma présente des données prometteuses sur le HDP-101 lors du congrès ADC 2025 Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Congrès ADC
BRIEF published on 11/03/2025 at 10:12, 10 months 19 days ago Heidelberg Pharma Reveals Promising Data for HDP-101 at ADC Congress 2025 Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC Congress
PRESS RELEASE published on 11/03/2025 at 10:07, 10 months 19 days ago Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar Heidelberg Pharma to present new clinical data of lead ADC candidate HDP-101 at the World ADC Congress 2025 and host a webinar. Study results show promising anti-tumor activity in multiple myeloma patients Webinar Clinical Data Heidelberg Pharma Multiple Myeloma ADC Candidate
Published on 09/22/2026 at 12:30, 3 minutes ago Jaguar Mining Commences New Underground Drilling Program Targeting Untested High-Grade Zones at Turmalina Mine, Brazil
Published on 09/22/2026 at 12:00, 33 minutes ago Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices
Published on 09/22/2026 at 11:30, 1 hour 3 minutes ago American Critical Minerals Completes Drilling Operations at the AP-S-02 Duma Point Well Confirming Potash Mineralization and Deep Brine Aquifers
Published on 09/22/2026 at 08:00, 4 hours 33 minutes ago Coretura Selects Alloy Kore to Advance a Unique Software-Defined Vehicle Platform for Its Commercial Vehicle Customers
Published on 09/22/2026 at 08:00, 4 hours 33 minutes ago Caledonia Mining Corporation PLC: Notification of Relevant Change to Significant Shareholder
Published on 09/22/2026 at 10:30, 2 hours 3 minutes ago Elke Eckstein appointed to the Supervisory Board of R. STAHL AG
Published on 09/22/2026 at 10:05, 2 hours 27 minutes ago Hedia Secures Regulatory Approval to Expand Digital Diabetes Care to Pediatric Patients
Published on 09/22/2026 at 09:55, 2 hours 37 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 09/21/2026 at 18:19, 18 hours 14 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 18 hours 14 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 18 hours 31 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 18 hours 47 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 18 hours 47 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026